slow and steady, page-2

Like I said in the other thread, I think this is reasonably positive news. The halving of the burn rate is what got me interested again. If they turn even a small profit next quarter, I can't see how it would still be hanging around the 2c mark. With so many distributors now, it's not like each one has to sell very many at all to pull in a million bucks for the quarter. Should head on back at least towards that barrier around 5 - 5.5c, if not further. Would expect pharma interest only above 100m mkt cap really. As far as MJ is concerned, I personally think he is so far out of his depth trying to get this thing to go that even floaties wouldn't help. All those millions of oppies expiring soon must be causing a sweat being valued at .001. At the end of the day, the CEO and the fund guys will be the driving force at some stage. All imo of course...